Fast Market Research

Now Available: Hepatocyte Growth Factor - Pipeline Review, H1 2016

LogoGlobal Markets Direct's, 'Hepatocyte Growth Factor (Hepatopoietin-A or Lung Fibroblast Derived Mitogen) - Pipeline Review, H1 2016', provides in depth analysis on Hepatocyte Growth Factor (Hepatopoietin-A or Lung Fibroblast Derived Mitogen) targeted pipeline therapeutics.

New Market Study, "Construction Equipment Market - Global Trends and Forecast to 2021", Has Been Published

LogoConstruction Equipment Market by Construction Equipment Type, Construction Application, Mining Equipment, by Mining Application, and Region (Asia-Pacific, North America, Europe, and ROW) - Global Trends and Forecast to 2021.

Recent Study: Chronic Myelocytic Leukemia Global Clinical Trials Review, H1, 2016

LogoGlobalData's clinical trial report, "Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Global Clinical Trials Review, H1, 2016" provides an overview of Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

Cladding Systems Market - Forecast to 2021 - New Report Available

LogoCladding Systems Market by Material (Wood, Brick & Stone, Vinyl, Stucco & EIFS, Metal, Fiber Cement), Component (Walls, Roofs, Windows & Doors), Function (Insulation, Air & Vapor Control, Precipitation Control), by Application - Forecast to 2021.

New Market Study, "U.S. Therapeutic Plasma Exchange Market - Forecasts to 2021", Has Been Published

LogoU.S. Therapeutic Plasma Exchange Market by Indication (Neurological & Autoimmune Disorders), Procedures & Patients (Guillain Barre Syndrome, Multiple Sclerosis, Myasthenia Gravis, Thrombotic Thrombocytopenic Purpura, Glomerulonephritis) - Forecasts to 2021.

Collagenase 3 (Matrix Metalloproteinase-13 or MMP13 or EC 3.4.24.) - Pipeline Review, H1 2016 - New Report Available

LogoGlobal Markets Direct's, 'Collagenase 3 (Matrix Metalloproteinase-13 or MMP13 or EC 3.4.24.) - Pipeline Review, H1 2016', provides in depth analysis on Collagenase 3 (Matrix Metalloproteinase-13 or MMP13 or EC 3.4.24.) targeted pipeline therapeutics.

HVAC Systems Market - Global Forecast to 2022 - New Market Research Report

LogoHVAC Systems Market by Equipment Type (Heating (Heat Pump, Furnace), Ventilation (Air Filter, Dehumidifier, Air Purifier), Cooling (Room AC, Unitary AC, Chiller)), Software & Services, Implementation Type, Application, and Geography - Global Forecast to 2022.

Smart-Phone Global Market - Forecast 2013 - 2020 - New Market Research Report

LogoThe global smart-phone market is expected to reach USD XX billion by 2020, with a CAGR of XX%. It is dominated by Asia-Pacific region with XX% market share, followed by Europe with XX% market share. Global smart-phone shipments are expected to reach XX million units by 2020.

New Market Study, "Bleeding Disorders Treatment Market - Global Forecast to 2021", Has Been Published

LogoBleeding Disorders Treatment Market by Type (Hemophilia A, Hemophilia B, vWD), Drug Class (Plasma Derived Coagulation Factor Concentrates, Recombinant Coagulation Factor Concentrates, Desmopressin, Antibrinolytics, Fibrin Sealant) - Global Forecast to 2021.

Cathepsin L (EC 3.4.22.15) - Pipeline Review, H1 2016 - New Report Available

LogoGlobal Markets Direct's, 'Cathepsin L (EC 3.4.22.15) - Pipeline Review, H1 2016', provides in depth analysis on Cathepsin L (EC 3.4.22.15) targeted pipeline therapeutics.